This portion of our Web site contains archived information. Archived Information contained or referenced herein should not be considered current and may no longer be accurate.
| Press Releases |
Nov 7, 2008
Dendreon Reports Third Quarter 2008 Financial Results |
 43.9 KB |
Nov 6, 2008
Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials |
14.2 KB |
Nov 5, 2008
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences |
10.2 KB |
Oct 23, 2008
Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist |
13.3 KB |
Oct 6, 2008
Dendreon Announces Interim Data from Phase 3 PROVENGE IMPACT Trial |
14.4 KB |
Oct 6, 2008
Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial |
11.3 KB |
Sep 17, 2008
Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference |
7.2 KB |
Aug 29, 2008
Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference |
7.3 KB |
Aug 14, 2008
Dendreon Initiates Second of Two New Phase 2 Trials |
10.4 KB |
Aug 12, 2008
Dendreon Reports Second Quarter 2008 Financial Results |
37.5 KB |
|
|
Download Library
Glossary
RSS News Feeds
Print page
Email page